Most studies recognize a relatively low expression of PD-L1, with a higher proportion of PD-L1-positive SCLC in early stages compared to extensive-disease SCLC (ED-SCLC) [47,48,49,50,51,52]. Here, CD274 is linked to small cell lung carcinoma.